Rating History for Inhibikase Therapeutics Inc (IKT) by BofA Securities
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/21/2026 | Jason Zemansky | New Coverage | Buy (N/A) |
6.00 (N/A) |
1.65 (1.87) |
13.33% | Details |
